Skip to content

The Prone to Supine Breast MRI Trial

The Prone to Supine Breast MRI Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03573804
Enrollment
72
Registered
2018-06-29
Start date
2018-07-12
Completion date
2020-07-31
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Breast Cancer Locator

Brief summary

The purpose of this study is to determine whether a supine MRI obtained immediately after a standard diagnostic prone MRI exam, without a second injection of gadolinium (Gd) contrast material, would be of sufficient quality to allow the Radiologist to define the tumor edges (segment the tumor) so that a 3-D image of the tumor can be generated to form a BCL.

Detailed description

The purpose of this study is to find out whether additional MRI images taken with patients in a different position after completing a standard MRI are of sufficient quality to allow a radiologist to identify the edges of the tumor. These additional MRI images will only take about 10-15 minutes to obtain and will not require a second injection of contrast material.The information gathered in this study will make it more feasible to use a new device called the breast cancer locator to help surgeons more accurately remove breast cancers.

Interventions

OTHERProne to Supine MRI

The patient will be placed in the prone position and undergo a standard Gd contrast-enhanced bilateral breast MRI. Immediately after the prone MRI is completed, the patient will be repositioned for the supine MRI. Prior to starting the prone MRI, the study MRI technician/investigator will explain to the patient and practice with the patient the steps needed to transition from the prone to the supine MRI, so as to facilitate a timely transition. Additional MRI images will only take about 10-15 minutes to obtain and will not require a second injection of contrast material.

Sponsors

Dartmouth-Hitchcock Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years. * Female gender. * Histologic diagnosis of invasive breast cancer or ductal carcinoma in situ * Tumor size at least 1 cm in diameter as visualized on mammogram or US. * A diagnostic breast MRI is considered to be clinically indicated. * Ability to voluntarily provide informed consent to participate prior to any study-related assessments/procedures being conducted.

Exclusion criteria

* Absolute contraindication to MRI, including presence of implanted electrical device (pacemaker or neurostimulator), aneurysm clip, or metallic foreign body in or near eyes. * Severe claustrophobia. * Contraindication to use of gadolinium-based intravenous contrast, including life- threatening allergy or compromised renal function (eGFR \< 30 ml/min/1.73m2). * History of median sternotomy. * Pregnancy. Patient attestation that they are not pregnant will be acceptable. * Patients who have received neoadjuvant chemotherapy.

Design outcomes

Primary

MeasureTime frameDescription
Number of Successful Segmentation of Supine MRI Images30 minutesDetermine what number of cases that can be successfully segmented both from using post-contrast prone MRI images and also from using post contrast supine MRI images.

Secondary

MeasureTime frameDescription
Enhancement Quantification, as Measured by Signal Intensity - Segmented Tumor30 minutesCompare the signal intensity with that obtained at tumor location on the prone and supine imaging. The amount of enhancement at the tumor site = segmented tumor.
Enhancement Quantification, as Measured by Signal Intensity - Tumor Boundary30 minutesCompare the signal intensity with that obtained in benign tissue surrounding the tumor on the prone and supine imaging.
Enhancement Quantification- Tumor-to-Background Ratio30 minutesMean MRI signal of the segmented tumor divided by the mean MRI signal of the surrounding tissue which has an equal volume to the tumor. The difference between tumor and benign breast tissue is the tumor-to-background ratio
Time to Position and Obtain Supine Images30 MinutesCalculate the additional time needed to obtain supine MRI images. After the completion of Prone imaging, the patient was removed from the MRI, turned over to the supine position, new coils placed, and returned to the MRI for additional imaging. The aggregate time to accomplish these tasks are noted in minutes.
Overall Comfort for Prone and Supine PositionsWithin 15 minutes of the scanQuantify the perceived comfort level of the prone and supine MRI as reported by participants. A single question using a Likert scale was was used. The scale range was 0 to 5, where 0 = no pain, completely comfortable and 5 = considerable discomfort.

Countries

United States

Participant flow

Participants by arm

ArmCount
Prone to Supine MRI
The patient will be placed in the prone position and undergo a standard Gd contrast-enhanced bilateral breast MRI. Immediately after the prone MRI is completed, the patient will be repositioned for the supine MRI. Prior to starting the prone MRI, the study MRI technician/investigator will explain to the patient and practice with the patient the steps needed to transition from the prone to the supine MRI, so as to facilitate a timely transition. Additional MRI images will only take about 10-15 minutes to obtain and will not require a second injection of contrast material. Prone to Supine MRI: The patient will be placed in the prone position and undergo a standard Gd contrast-enhanced bilateral breast MRI. Immediately after the prone MRI is completed, the patient will be repositioned for the supine MRI. Prior to starting the prone MRI, the study MRI technician/investigator will explain to the patient and practice with the patient the steps needed to transition from the prone to the supine MRI, so as to facilitate a timely transition. Additional MRI images will only take about 10-15 minutes to obtain and will not require a second injection of contrast material.
72
Total72

Withdrawals & dropouts

PeriodReasonFG000
Overall Studyclaustrophobia or MRI table problems10

Baseline characteristics

CharacteristicProne to Supine MRI
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
18 Participants
Age, Categorical
Between 18 and 65 years
54 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
68 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
2 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
Race (NIH/OMB)
White
71 Participants
Region of Enrollment
United States
72 Participants
Sex: Female, Male
Female
72 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 62
other
Total, other adverse events
0 / 62
serious
Total, serious adverse events
0 / 62

Outcome results

Primary

Number of Successful Segmentation of Supine MRI Images

Determine what number of cases that can be successfully segmented both from using post-contrast prone MRI images and also from using post contrast supine MRI images.

Time frame: 30 minutes

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Prone to Supine MRI Evaluated by Radiologist ANumber of Successful Segmentation of Supine MRI Images54 Participants
Prone to Supine MRI Evaluated by Radiologist BNumber of Successful Segmentation of Supine MRI Images61 Participants
Secondary

Enhancement Quantification, as Measured by Signal Intensity - Segmented Tumor

Compare the signal intensity with that obtained at tumor location on the prone and supine imaging. The amount of enhancement at the tumor site = segmented tumor.

Time frame: 30 minutes

Population: One participant was not able to complete both the Prone and Supine Imaging and was excluded.

ArmMeasureValue (MEAN)
Prone to Supine MRI Evaluated by Radiologist AEnhancement Quantification, as Measured by Signal Intensity - Segmented Tumor370.09 Tesla per second
Prone to Supine MRI Evaluated by Radiologist BEnhancement Quantification, as Measured by Signal Intensity - Segmented Tumor594.77 Tesla per second
Comparison: Regions of interest (ROIs) for tumor were defined by the radiologist segmentation of tumor in supine and prone positions. ROIs for the surrounding tissue were selected such that tumor and normal regions had equal volumes. The alpha level was assumed to be of 0.05 (dof = 60), and the null hypothesis of equivalence (mu = 0).p-value: <0.00195% CI: [90.26044, 359.08956]t-test, 2 sided
Secondary

Enhancement Quantification, as Measured by Signal Intensity - Tumor Boundary

Compare the signal intensity with that obtained in benign tissue surrounding the tumor on the prone and supine imaging.

Time frame: 30 minutes

Population: One participant was not able to complete both the Prone and Supine Imaging and was excluded.

ArmMeasureValue (MEAN)
Prone to Supine MRI Evaluated by Radiologist AEnhancement Quantification, as Measured by Signal Intensity - Tumor Boundary217.96 Tesla per second
Prone to Supine MRI Evaluated by Radiologist BEnhancement Quantification, as Measured by Signal Intensity - Tumor Boundary383.80 Tesla per second
Comparison: Regions of interest (ROIs) for surrounding tissues were selected as the surrounding benign tissue regions directly adjacent to the segmented tumor regions. Tumor and surrounding regions had equal volumes. The mean surrounding region intensities reported were all calculated from the prone and supine T1-weighted MR images segmented by the radiologist.p-value: <0.00195% CI: [78.34708, 253.31892]t-test, 2 sided
Secondary

Enhancement Quantification- Tumor-to-Background Ratio

Mean MRI signal of the segmented tumor divided by the mean MRI signal of the surrounding tissue which has an equal volume to the tumor. The difference between tumor and benign breast tissue is the tumor-to-background ratio

Time frame: 30 minutes

Population: One participant was not able to complete both the Prone and Supine Imaging and was excluded.

ArmMeasureValue (MEAN)
Prone to Supine MRI Evaluated by Radiologist AEnhancement Quantification- Tumor-to-Background Ratio1.74 Ratio
Prone to Supine MRI Evaluated by Radiologist BEnhancement Quantification- Tumor-to-Background Ratio1.62 Ratio
Comparison: The ratios of tumor-to-surrounding tissue intensities, as calculated in Secondary Objective Part A, were compared between prone and supine T1-weighted MR image scans.p-value: 0.005895% CI: [-0.04209, 0.28209]t-test, 2 sided
Secondary

Overall Comfort for Prone and Supine Positions

Quantify the perceived comfort level of the prone and supine MRI as reported by participants. A single question using a Likert scale was was used. The scale range was 0 to 5, where 0 = no pain, completely comfortable and 5 = considerable discomfort.

Time frame: Within 15 minutes of the scan

Population: This assessment of overall perceived comfort was added to the study during the study period, and only the last 28 patients evaluated their overall comfort with the prone and supine portions of the examination.

ArmMeasureValue (MEAN)
Prone to Supine MRI Evaluated by Radiologist AOverall Comfort for Prone and Supine Positions1.82 units on a scale
Prone to Supine MRI Evaluated by Radiologist BOverall Comfort for Prone and Supine Positions0.61 units on a scale
p-value: 0.00049664Students two-tailed paired t-test
Secondary

Time to Position and Obtain Supine Images

Calculate the additional time needed to obtain supine MRI images. After the completion of Prone imaging, the patient was removed from the MRI, turned over to the supine position, new coils placed, and returned to the MRI for additional imaging. The aggregate time to accomplish these tasks are noted in minutes.

Time frame: 30 Minutes

ArmMeasureValue (MEDIAN)
Prone to Supine MRI Evaluated by Radiologist ATime to Position and Obtain Supine Images7.25 minutes

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026